KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $215,159 | -54.5% | 7,208 | -38.7% | 0.03% | -50.0% |
| Q1 2024 | $472,471 | +188.9% | 11,753 | +83.0% | 0.06% | +87.5% |
| Q4 2023 | $163,530 | +727.9% | 6,423 | +352.0% | 0.03% | +433.3% |
| Q3 2023 | $19,752 | +18.5% | 1,421 | +96.0% | 0.01% | +20.0% |
| Q2 2023 | $16,668 | -24.8% | 725 | -3.1% | 0.01% | -37.5% |
| Q1 2023 | $22,163 | +59.4% | 748 | +34.3% | 0.01% | +33.3% |
| Q4 2022 | $13,903 | +26.4% | 557 | +14.8% | 0.01% | +20.0% |
| Q3 2022 | $11,000 | – | 485 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 5,350,422 | $159,710,097 | 16.82% |
| Aquilo Capital Management, LLC | 328,743 | $9,812,979 | 9.46% |
| BVF INC/IL | 5,161,801 | $154,079,760 | 4.32% |
| Redmile Group, LLC | 1,579,275 | $47,141,359 | 2.85% |
| Deer Management Co. LLC | 415,895 | $12,414,466 | 2.55% |
| Artal Group S.A. | 3,005,610 | $89,717,459 | 2.29% |
| Baker Brothers Advisors | 5,995,928 | $178,978,451 | 2.29% |
| Avoro Capital Advisors LLC | 3,888,888 | $116,083,307 | 1.55% |
| Checkpoint Capital L.P. | 82,000 | $2,447,700 | 1.48% |
| Deep Track Capital, LP | 1,500,000 | $44,775,000 | 1.34% |